New onset refractory status epilepticus: Summary of the NORSE Institute roundtable during the 2023 American Epilepsy Society meeting, Orlando, Florida

EpilepsiaVolume 65, Issue 4 p. 1145-1146 LETTER New onset refractory status epilepticus: Summary of the NORSE Institute roundtable during the 2023 American Epilepsy Society meeting, Orlando, Florida Aurélie Hanin, Aurélie Hanin orcid.org/0000-0002-5912-9998 Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France Assistance Publique - Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, DMU Neurosciences, Epilepsy Unit and Department of Clinical Neurophysiology, Paris, FranceSearch for more papers by this authorKrista Eschbach, Krista Eschbach orcid.org/0000-0002-4249-338X Department of Pediatrics, Section of Neurology, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado, USASearch for more papers by this authorTeneille E. Gofton, Teneille E. Gofton orcid.org/0000-0001-9001-4884 University Hospital, London Health Sciences Center, London, Ontario, CanadaSearch for more papers by this authorMargaret Gopaul, Margaret Gopaul Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USASearch for more papers by this authorCharles L. Howe, Charles L. Howe orcid.org/0000-0002-3889-8739 Department of Neurology, Mayo Clinic, Rochester, Minnesota, USASearch for more papers by this authorYi-Chen Lai, Yi-Chen Lai orcid.org/0000-0002-9450-5506 Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USASearch for more papers by this authorSookyong Koh, Sookyong Koh Children's Hospital and Medical Center, Department of Pediatrics, University of Nebraska, Omaha, Nebraska, USASearch for more papers by this authorHaying Shen, Haying Shen Children's Hospital and Medical Center, Department of Pediatrics, University of Nebraska, Omaha, Nebraska, USASearch for more papers by this authorLawrence J. Hirsch, Corresponding Author Lawrence J. Hirsch [email protected] orcid.org/0000-0002-6333-832X Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA Correspondence Lawrence J. Hirsch, Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, CT, USA. Email: [email protected]Search for more papers by this author Aurélie Hanin, Aurélie Hanin orcid.org/0000-0002-5912-9998 Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France Assistance Publique - Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, DMU Neurosciences, Epilepsy Unit and Department of Clinical Neurophysiology, Paris, FranceSearch for more papers by this authorKrista Eschbach, Krista Eschbach orcid.org/0000-0002-4249-338X Department of Pediatrics, Section of Neurology, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado, USASearch for more papers by this authorTeneille E. Gofton, Teneille E. Gofton orcid.org/0000-0001-9001-4884 University Hospital, London Health Sciences Center, London, Ontario, CanadaSearch for more papers by this authorMargaret Gopaul, Margaret Gopaul Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USASearch for more papers by this authorCharles L. Howe, Charles L. Howe orcid.org/0000-0002-3889-8739 Department of Neurology, Mayo Clinic, Rochester, Minnesota, USASearch for more papers by this authorYi-Chen Lai, Yi-Chen Lai orcid.org/0000-0002-9450-5506 Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USASearch for more papers by this authorSookyong Koh, Sookyong Koh Children's Hospital and Medical Center, Department of Pediatrics, University of Nebraska, Omaha, Nebraska, USASearch for more papers by this authorHaying Shen, Haying Shen Children's Hospital and Medical Center, Department of Pediatrics, University of Nebraska, Omaha, Nebraska, USASearch for more papers by this authorLawrence J. Hirsch, Corresponding Author Lawrence J. Hirsch [email protected] orcid.org/0000-0002-6333-832X Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA Correspondence Lawrence J. Hirsch, Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, CT, USA. Email: [email protected]Search for more papers by this author First published: 29 February 2024 https://doi.org/10.1111/epi.17934Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Hirsch LJ, Gaspard N, van Baalen A, Nabbout R, Demeret S, Loddenkemper T, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018; 59(4): 739–744. 10.1111/epi.14016 PubMedWeb of Science®Google Scholar 2Hanin A, Cespedes J, Dorgham K, Pulluru Y, Gopaul M, Gorochov G, et al. Cytokines in new-onset refractory status epilepticus predict outcomes. Ann Neurol. 2023; 94(1): 75–90. 10.1002/ana.26627 CASPubMedWeb of Science®Google Scholar 3Cerovic M, Di Nunzio M, Craparotta I, Vezzani A. An in vitro model of drug-resistant seizures for selecting clinically effective antiseizure medications in febrile infection-related epilepsy syndrome. Front Neurol. 2023; 14:1129138. 10.3389/fneur.2023.1129138 PubMedWeb of Science®Google Scholar 4Howe CL, Johnson RK, Overlee BL, Sagen JA, Mehta N, Farias-Moeller R. Drug-resistant seizures associated with hyperinflammatory monocytes in FIRES. Ann Clin Transl Neurol. 2023; 10(5): 719–731. 10.1002/acn3.51755 CASPubMedWeb of Science®Google Scholar 5Kang JW, Koh S. Interleukin-1 in febrile infection-related epilepsy syndrome. Ann Child Neurol. 2023; 31(3): 151–160. 10.26815/acn.2023.00031 Google Scholar 6Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015; 85(18): 1604–1613. 10.1212/WNL.0000000000001940 PubMedWeb of Science®Google Scholar 7Taraschenko O, Pavuluri S, Schmidt CM, Pulluru YR, Gupta N. Seizure burden and neuropsychological outcomes of new-onset refractory status epilepticus: systematic review. Front Neurol. 2023; 14:1095061. 10.3389/fneur.2023.1095061 PubMedWeb of Science®Google Scholar 8Wu J, Lan X, Yan L, Hu Y, Hong S, Jiang L, et al. A retrospective study of 92 children with new-onset refractory status epilepticus. Epilepsy Behav. 2021; 125:108413. 10.1016/j.yebeh.2021.108413 PubMedWeb of Science®Google Scholar 9Hanin A, Cespedes J, Pulluru Y, Gopaul M, Aronica E, Decampo D, et al. Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus. Epilepsia. 2023; 64(6): 1444–1457. 10.1111/epi.17600 CASPubMedWeb of Science®Google Scholar Volume65, Issue4April 2024Pages 1145-1146 ReferencesRelatedInformation